Nicholas Flytzanis
About Nicholas Flytzanis
Nicholas Flytzanis Founder and Chief Research and Innovation Officer
Nicholas Flytzanis holds the title of Founder and Chief Research and Innovation Officer. His role involves leading the strategic research initiatives and guiding innovative approaches within the company. Flytzanis is instrumental in driving the company's mission and vision, particularly in the field of gene therapy.
Nicholas Flytzanis Education and Expertise
Nicholas Flytzanis was a Ph.D. student in the laboratory of Viviana Gradinaru, a neuroscience professor at Caltech. During his academic tenure, Flytzanis developed significant expertise in neuroscience and gene therapy. His research background has provided him with a strong foundation in these fields, which he has leveraged in his professional endeavors.
Background of Nicholas Flytzanis
Nicholas Flytzanis has a solid background in neuroscience research. While working in the laboratory of Viviana Gradinaru at Caltech, he met Nick Goeden. Their collaboration led to a focus on translating their research into practical applications, specifically through the development of an AAV gene therapy platform.
Co-Founding of Capsida by Nicholas Flytzanis
Nicholas Flytzanis co-founded Capsida after developing the concept with Nick Goeden. The idea for the company took shape during a lunch at a restaurant named Nick's. Their shared vision and expertise in gene therapy laid the foundation for Capsida, a company dedicated to advancing gene therapy solutions.